Results

SMC Announces Marketing Agreement with Plato Technologies. Inc.

Source Node:
Time Stamp: April 19, 2024 5:44 AM - Modified On: April 19, 2024 - Published By:
Source Cluster:
Republished By Plato

  BOCA RATON, FL / Plato / Amplifi / April 18,2024 / SMC Entertainment, Inc. ("SMC" or the "Company") (OTC PINK: SMCE) SMC / (PINK:SMCE) is pleased to announce a marketing agreement and collaboration with Plato Technologies Inc. Plato Technologies specializes in AI content disruption and AI management systems. The collaboration will enable the Company to market Plato's platform directly to web and content development teams. The companies have agreed on a revenue sharing agreement after deducting individual client acquisition costs. "This is just the beginning." stated Erik Blum CEO

Gome Fin Tech Announced Annual Results of 2023

Source Node:
Time Stamp: April 1, 2024 1:18 PM - Modified On: April 1, 2024 - Published By:
Source Cluster:
Republished By Plato

  Commercial Factoring Progresses Despite Stability Diversified Businesses Ready for Development HONG KONG, Mar 29, 2024 - (ACN Newswire) - Gome Finance Technology Co., Ltd.(Stock Code:628.HK,“Gome Fin Tech”or “the Company”,with its subsidiaries,the“Group”), announced its audited annual results for the year ended 31 December, 2023 (the “Reporting Period”). In 2023, the global geopolitical risks are frequent, the lack of economic recovery momentum and the widening trend of differentiation among countries are highlighted, and the risk spillover from European and US banks under the global high interest rate environment also casts a

Kaskade Finance Closes Successful Pre-Seed Round

Source Node:
Time Stamp: March 11, 2024 3:14 PM - Modified On: March 11, 2024 - Published By:
Source Cluster:
Republished By Plato

Kaskade finance, a gamified incentivization layer protocol, just announced the closure of its pre-seed funding round from over 40 investors. Kaskade Finance Nathan Lenga, CEO of Kaskade, tabled the MVP to go live in August, and to continue to build a world-class team that will make certain Kaskade Finance is the premier liquidity incentivization layer for all of DeFi. The oversubscribed seed round had participation from over 40 investors, some of which include Marshland, NxGen.xyz, Artemis Capital, Andromeda Capital, Hercules Ventures, 369 Capital, Crypto Oasis Ventures, as well as influencers,

Latest Survey from Sotera Digital Reveals Shocking State of Mobile Phone Security in the Workplace.

Source Node:
Time Stamp: February 5, 2024 8:17 AM - Modified On: February 5, 2024 - Published By:
Source Cluster:
Republished By Plato

February 5, 2024, New York - Sotera Digital Security, a leading US based provider of secure communications solutions, has today released its findings from a survey it conducted among over 1,000 senior personnel of large businesses and multinational corporations across the globe. Sectors covered by the survey participants focused on those that require the need for ultra-secure and private communications - both regionally and worldwide - with clients, colleagues and suppliers; namely legal, pharmaceutical, media and corporate affairs, government, and blockchain / AI tech specialists. The survey results provide key

Plato Data Intelligence Leverages Vectara to Power its Data-As-A-Service / DaaS Platform

Source Node:
Time Stamp: January 18, 2024 1:35 PM - Modified On: January 18, 2024 - Published By:
Source Cluster:
Republished By Plato

From development to launch, Vectara’s GenAI technology and team help innovators get to market faster. The announced partnership breaks new ground towards deploying a next generation of GenAI tools with Vertical focus. Vectara, the Trusted Generative AI Product Platform, and Plato Data Intelligence, creators of PlatoAi, have entered into a commercial agreement to unlock the power of Vectara via Plato AI’s Generative Intelligence platform. With an emphasis on secure, trustworthy, and transparent GenAI for enterprises, Vectara was the clear choice for developers who want a trusted provider to count on

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

GPO Plus, Inc. (GPOX) Achieves Record Revenues with 25% Quarterly Growth

Source Node:
Time Stamp: December 18, 2023 1:35 PM - Modified On: December 18, 2023 - Published By:
Source Cluster:
Republished By Plato

December 18, 2023 - GPO Plus, Inc. (OTCQB: GPOX), a prominent distribution and manufacturing company specializing in consumer products for convenience stores, gas stations, and specialty retailers, has reported impressive Q2 financial results. The company's gross revenue for the quarter ending October 31, 2023, reached a record $1.21 million, marking a substantial 25% increase from the previous quarter ending July 31, 2023, which reported $970,735 in gross revenues. Key Highlights: Quarterly Revenue Surge: GPOX achieved a remarkable 25% surge in top-line revenue, reaching $1.213 million in the second quarter, up

Zero-G Racetrack Rides into New Territory with Electro-Western Anthem “Never Ride Alone”

Source Node:
Time Stamp: October 6, 2023 12:17 PM - Modified On: October 6, 2023 - Published By:
Source Cluster:
Republished By Plato

[Silicon Valley, October 6, 2023] - Zero-G Racetrack, Silicon Valley’s up and coming Electronic Rock artists, are back with their latest single, "Never Ride Alone”, seamlessly combining the storytelling of classic country western legends with the retro-future allure of Electronic Rock. Zero-G Racetrack has been gaining recognition for their unique approach of using various genre callbacks within the context of electronic dance music. With “Never Ride Alone”, Zero-G Racetrack tips their hat to the compelling Western tales spun by legends like Johnny Cash and Waylon Jennings, setting out to bring

Revolutionizing Clinical Trials: The Digital Watermarking and AI Duo

Source Node:
Time Stamp: October 5, 2023 11:22 AM - Modified On: October 5, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionizing Clinical Trials: The Digital Watermarking and AI Duo Clinical trials, the linchpin of medical research, have long been riddled with inefficiencies, from patient recruitment bottlenecks to data management hurdles. As a technology and banking analyst, I've seen how digital solutions can overhaul entire sectors, offering improved productivity and streamlined processes. It's high time that clinical trials get a dose of such digital innovation, and there's a potent combination on the horizon: digital watermarking coupled with Artificial Intelligence (AI). At first glance, one might wonder: how can a technique often

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Source Node:
Time Stamp: September 20, 2023 8:35 AM - Modified On: September 20, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers